Références

Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA): www.ginasthma.com (Guidelines.)

Bauer, Carl-Peter und Rutsch, Sabine: Asthma auf einen Blick. Blackwell Verlag 2003.

Kroegel, Claus: Asthma bronchiale. Pathogenetische Grundlagen, Diagnostik, Therapie. Georg Thieme Verlag, 2. Auflage 2002.

Rabe KF, et al. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16(5):802-7.

Bateman ED, et al. Can Guideline-defined Asthma Control Be Achieved? The Gaining Optimal Asthma ControL Study. Am J Respir Crit Care Med 2004;170:836-44.

Humbert M, et al. Benefits of omalizumab in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005;60:309-316.

Novartis Pharma GmbH, Deutschland, Allergie und Atemwegskompetenz: www.asthma.de